Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Oncoclínicas Group records a net revenue of BRL 41 million for Q123 2023-05-22 11:18
One BioMed Announce World's First Fully Integrated Platform for Automated High Molecular Weight DNA Extraction 2023-05-22 08:00
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 2023-05-21 22:23
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 21:00
Daewoong Pharmaceutical Presents New Clinical Data of Fexuprazan at Digestive Disease Week 2023 2023-05-19 20:00
2023 Qingdao∙ Global Venture Capital Conference Comes to a Close 2023-05-19 20:00
The 133rd Canton Fair Gathers Top Medical Equipment to Unlock the Health Code 2023-05-19 19:49
Hisense HD60 Demonstrated in Clinical Training at University Hospital of Valdecilla in Spain 2023-05-19 19:37
HanAll Biopharma Announces Results from Phase III randomized, double-masked active treatment-controlled VELOS-3 Trial Evaluating Tanfanercept 0.25% for Treatment of Dry Eye Disease 2023-05-19 19:00
Another Hisense HD60 Ultrasound Installation at Vaal Radiology, South Africa 2023-05-19 17:58
Improved Overall Health, Better Sleep, and Enhanced Immunity Ranked as Top Three Health Goals by Increasingly Health-Conscious Asia Pacific Consumers - Herbalife Survey 2023-05-19 16:38
ExoCoBio obtained a US Patent for Rose Stem Cell-derived Exosome (RSCE™) 2023-05-19 16:34
Positive Results from Interim Analysis of 'GEN-001' Plus avelumab (Bavencio®) Phase II Trial 2023-05-19 16:00
EuroPCR 2023 | 6 Month Outcome of the SMART Study: satisfactory BP control achieved with reduced medication burden 2023-05-19 14:54
The Seventy-sixth World Health Assembly: Urgent global action to prioritise mental health 2023-05-19 06:00
Endogenex™ Appoints Christopher Sorli as Chief Medical Officer 2023-05-18 22:00
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. 2023-05-18 21:23
Neurophet receives FDA 510(k) Clearance for Neurophet AQUA 2023-05-18 21:00
CARsgen Initiates Phase 2 Clinical Trial for CLDN18.2 CAR T-cell Product CT041 in the U.S. 2023-05-18 20:50
1 196 197 198 199 200 970